Home Archives 2012 December

Monthly Archives: December 2012

Drug Patent Expirations for December 2012

TradenameApplicantGeneric NamePatent NumberPatent Expiration
NUTROPIN DEPOTGenentechsomatropin recombinant6,051,259Dec 2, 2012
ATACAND HCTAstrazenecacandesartan cilexetil; hydrochlorothiazide5,196,444*PEDDec 4, 2012
ATACANDAstrazenecacandesartan cilexetil5,196,444*PEDDec 4, 2012
PAXIL CRGlaxosmithklineparoxetine hydrochloride5,422,123*PEDDec 6, 2012
COMBIPATCHNovartisestradiol; norethindrone acetate5,958,446Dec 12, 2012
MUSEMeda Pharmsalprostadil5,474,535Dec 12, 2012
PROHANCEBraccogadoteridol5,474,756Dec 12, 2012
PROHANCE MULTIPACKBraccogadoteridol5,474,756Dec 12, 2012
DAYTRANANoven Pharms Incmethylphenidate5,958,446Dec 12, 2012
VIVELLE-DOTNovartisestradiol5,958,446Dec 12, 2012
COMBIPATCHNovartisestradiol; norethindrone acetate5,474,783Dec 12, 2012
PROHANCEBraccogadoteridol6,143,274Dec 12, 2012
PROHANCE MULTIPACKBraccogadoteridol6,143,274Dec 12, 2012
VIVELLE-DOTNovartisestradiol5,474,783Dec 12, 2012
ALPHAGAN PAllerganbrimonidine tartrate5,424,078*PEDDec 13, 2012
SYMBICORTAstrazenecabudesonide; formoterol fumarate dihydrate5,972,919Dec 17, 2012
TASMARValeant Pharms Llctolcapone5,476,875Dec 19, 2012
ASMANEX TWISTHALERScheringmometasone furoate5,394,868*PEDDec 25, 2012
SPIRIVABoehringer Ingelheimtiotropium bromide monohydrate5,478,578Dec 26, 2012
MAXALT-MLTMerckrizatriptan benzoate5,298,520*PEDDec 29, 2012
MAXALTMerckrizatriptan benzoate5,298,520*PEDDec 29, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.